Viz AAA

by Viz.ai  · Based in United States → — The proven AI-powered care coordination platform.
Emergency Medicine Radiology Vascular Surgery

Enterprise (hospital/health system)
Regulatory Status Disclosed

Overview

Viz AAA is an AI-powered solution developed by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA). The tool utilizes artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from computed tomography angiography (CTA) scans from any scanner within a hospital network.

As part of the broader Viz™ AORTIC Module and the comprehensive Viz.ai One™ platform, Viz AAA integrates into existing hospital workflows, enabling care teams to quickly identify patients who may have a suspected AAA. This accelerated detection and triage are crucial for preventing catastrophic aortic emergencies, such as aortic rupture, by increasing the surveillance of these patients and facilitating faster treatment decisions.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered automatic detection of suspected AAA from CTA scans
  • Automated triage and prioritization of cases
  • Integration into existing hospital workflows
  • Real-time alerts to care teams
  • HIPAA-compliant communication platform for multidisciplinary teams
  • Mobile access to high-fidelity imaging and patient information
  • Part of the Vizu2122 AORTIC Module for comprehensive aortic pathology solutions
  • Designed to accelerate treatment decisions and improve patient outcomes

Use Cases

  • Early detection of suspected Abdominal Aortic Aneurysms
  • Rapid triage of AAA cases to appropriate specialists
  • Prevention of catastrophic aortic emergencies like rupture
  • Increasing surveillance and follow-up for AAA patients
  • Streamlining care coordination for vascular conditions
  • Optimizing radiology workflow for incidental AAA findings

What Physicians Need to Know

ECG/EKG Analysis Capability
The Viz.ai platform analyzes EKGs and includes a publication on the 'Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence'.
Echocardiography AI Features
The Viz.ai platform analyzes echocardiograms.
Cardiac CT/MRI Analysis
The Viz.ai platform analyzes CT scans and is used for conditions like Aortic Disease and Cardiac Amyloidosis.
Coronary Artery Assessment
The Viz Cardio Suite includes solutions for Acute Coronary Syndrome (ACS).
Real-Time Alert Capability
The platform delivers real-time insights and automated assessments, enabling real-time communications and connecting teams within seconds of suspected disease.
Physician Tip

Viz.ai's AI-powered care coordination platform, with over 50 FDA-cleared algorithms, can accelerate diagnosis and streamline workflows for cardiovascular conditions like Hypertrophic Cardiomyopathy, Acute Coronary Syndrome, and Cardiac Amyloidosis. The platform analyzes various imaging data, including EKGs, echocardiograms, and CT scans, providing real-time insights and automated assessments to support faster treatment decisions. Physicians can leverage the real-time communication features to activate care teams quickly upon detection of suspected diseases.

The Viz.ai platform is designed for easy integration and is supported by dedicated 24/7 on-call clinical specialists, implementation experts, and a customer success team. It also has pilot programs with Microsoft Cloud for Healthcare.

Details

Category Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Enterprise (hospital/health system)
DeploymentCloud-based, integrates with PACS and EHR systems.
Mobile App1
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
SOC 2 Yes AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Radiology, Vascular Surgery

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2023-03-17K223443 510(k)Viz AAA

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Viz AAA

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Viz AAA.

View all on YouTube

Frequently Asked Questions

The provided text mentions "Aortic Disease" under the Viz Vascular Suite, indicating its relevance to aortic conditions. However, it does not specifically detail how Viz AAA assists in the detection and management of Aortic Aneurysms, nor does it explicitly mention a product named "Viz AAA".
Viz.ai states that its comprehensive platform features more than 50 FDA-cleared AI algorithms. This indicates adherence to regulatory standards for its AI solutions, including those within the cardiovascular suite.
The provided text does not mention alternative AI solutions that integrate with Viz.ai's platform. It focuses on Viz.ai's own comprehensive AI-powered care coordination platform and its various suites.
The provided text does not contain any information regarding the pricing model for Viz.ai's cardiovascular AI suite or different tiers of service. Pricing details are not available in the given source material.
The provided text does not explicitly detail the known limitations or potential biases of Viz.ai's AI algorithms in cardiology. It highlights the benefits and capabilities of the platform, such as accelerating diagnosis and streamlining workflows.
The text mentions a "Trust Center" and links to various privacy policies (US Privacy Policy, EU Platform User Privacy Policy, EU Non Platform User Privacy Policy, Trust Center Privacy Notice). This indicates that Viz.ai addresses data privacy and security, though specific details on how it's ensured for cardiovascular cases are not provided in the excerpt.
The text indicates that Viz.ai works with life sciences partners to develop new, customized solutions for treatable diseases. This suggests a potential for customization, though specific details about hospital protocols or research initiatives are not explicitly outlined.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Viz.ai

Viz ANEURYSM
Viz.ai
Neurology AI
ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.
Viz CTP
Viz.ai
Clinical Decision Support & Reference
Viz.
Viz HCM
Viz.ai
Cardiology AI
ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Viz HDS
Viz.ai
Neurology AI
ai that automates the identification, labeling, and quantification of intracranial hyperdensities, lateral ventricles, and midline shift on non-contrast CT images, enhancing the speed and accuracy of diagnosis and care coordination for conditions like intracranial hemorrhage.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-15 | First Added: 2026-04-19

Investors who backed Viz AAA

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.